Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Dividend & Equity Income · AMG

AMG River Road Dividend All Cap Value Fund CLASS Z SHARES (ARZDX)

Ticker ARZDX · Since 2017-09-29 · · Holdings as of Jul 31, 2026

Expense ratio
0.68%$68/yr per $10k
5-yr return
+8.7%annualized
1-yr return
+7.4%as of Dec 2025
Net assets
$67.7Mall share classes
Holdings
64

Bottom line

Is ARZDX a good fund? The bottom line

ARZDX is the CLASS Z share class of AMG River Road Dividend All Cap Value Fund, a managed dividend & equity income mutual fund from AMG.

It charges 0.68% — about $68 a year on every $10,000 invested, cheaper than 55% of dividend & equity income funds we track.

It returned +7.4% over one year, +8.7% a year over five years (as of Dec 31, 2025, per its prospectus).

With $67.7 million in net assets and 64 holdings, its largest position is Royalty Pharma Plc (3.7%) and the top 10 make up 28.3% of the portfolio.

Updated Nov 19, 2026

What ARZDX invests in

The Fund seeks to provide high current income and,

Under normal conditions, the Fund invests at least 80% of its assets in equity securities. The Fund invests in a diversified, all-cap portfolio of income-producing equity securities with yields that River Road Asset Management, LLC, the subadviser to the Fund (River Road or the Subadviser), believes will exceed that of the Russell 3000 Value Index. The Fund invests primarily in dividend paying common stocks, publicly traded partnerships (PTPs), and real estate investment trusts (REITs). The Fund may also invest in foreign securities (directly and through depositary receipts), convertible preferred stocks, and royalty income trusts. The Subadvisers investment philosophy is based upon its proprietary Absolute Value approach, which seeks to generate attractive, sustainable returns over the long term, with an emphasis on minimizing downside portfolio risk. The Subadviser builds the Funds…

From the fund's prospectus (filed Feb 27, 2026).

ARZDX performance

Average annual total returns
1 yr5 yr10 yr
ARZDX+7.4%+8.7%—
Dividend & Equity Income median+14.6%+10.1%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full ARZDX performance history →

What ARZDX costs

On a $10,000 investment, ARZDX's 0.68% expense ratio costs about $68 a year. The prospectus estimates $1,001 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.

See the full ARZDX fee table →

ARZDX top 10 holdings

#Holding% of fund
1Royalty Pharma Plc RPRX3.65%
2Pnc Financial Services Group Inc (the) PNC3.33%
3Chubb Ltd (switzerland) CB3.05%
4Williams Companies Inc (the) WMB3.04%
5Texas Instruments Inc TXN2.93%
6Wells Fargo & Company WFC2.62%
7International Flavors & Fragrances Inc IFF2.54%
8Progressive Corp (the) PGR2.43%
9Kinder Morgan Inc KMI2.39%
10Starbucks Corp SBUX2.30%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 28.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to ARZDX

More funds like ARZDX →

ARZDX FAQ

What is the expense ratio of ARZDX?
ARZDX's expense ratio is 0.68%, which works out to about $68 a year for every $10,000 invested. The prospectus estimates total costs of $1,001 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ARZDX a good investment?
It depends on your goals, but the data points to: a typical fund for its category. This is general information, not personalized advice.
What does ARZDX hold?
ARZDX's largest holdings are Royalty Pharma Plc (3.7%), Pnc Financial Services Group Inc (the) (3.3%), Chubb Ltd (switzerland) (3.0%), Williams Companies Inc (the) (3.0%), Texas Instruments Inc (2.9%). It holds 64 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is ARZDX's 5-year return?
ARZDX returned +8.7% a year over the five years ending Dec 31, 2025. Past performance does not guarantee future results.
Who manages ARZDX?
ARZDX is offered by AMG through AMG Funds IV.